Axial Therapeutics Leadership

David is a senior executive with over 20 years of professional experience and expertise leading business development, venture teams and demonstrated track record of company creation. Visionary for launching one of the first CNS companies focused on the gut-brain axis and leader of the organization from inception through Phase 2 development. Operational expertise in both early-stage organizations (Axial, Surface Logix) and international organizations (AbbVie, GSK, Accenture and Dow). Seasoned relationship builder with expertise in fundraising, forging strategic partnerships, M&A and building world class SABs and management teams in biotech and biopharma. Founding executive of a precision CNS Company and board member of a medical device company. Also, experienced investor with several successful exits. David holds a BA in Chemistry from St. Anselm College, a Ph.D. in Polymer Chemistry from the University of Massachusetts Lowell, and an MBA from the University of North Carolina. He currently serves on the Board of Alcyone Life Sciences and Anuncia.

David is a senior executive with over 20 years of professional experience and expertise leading business development, venture teams and demonstrated track record of company creation. Visionary for launching one of the first CNS companies focused on the gut-brain axis and leader of the organization from inception through Phase 2 development. Operational expertise in both early-stage organizations (Axial, Surface Logix) and international organizations (AbbVie, GSK, Accenture and Dow). Seasoned relationship builder with expertise in fundraising, forging strategic partnerships, M&A and building world class SABs and management teams in biotech and biopharma. Founding executive of a precision CNS Company and board member of a medical device company. Also, experienced investor with several successful exits. David holds a BA in Chemistry from St. Anselm College, a Ph.D. in Polymer Chemistry from the University of Massachusetts Lowell, and an MBA from the University of North Carolina. He currently serves on the Board of Alcyone Life Sciences and Anuncia.